Home › Funds › BIOS Capital Management, LP › ACTU

BIOS Capital Management, LP position in ACTU

ACTUATE THERAPEUTICS INC · Health Care

BIOS Capital Management, LP reported holding 10,049,996 shares of ACTU (ACTUATE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.84B, representing 22.94% of its reported portfolio and ranking #2 among its reported holdings. BIOS Capital Management, LP has disclosed ACTU holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)10.05M sh
Reported value held$7.84B
Portfolio Weight22.94%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How BIOS Capital Management, LP's ACTU position evolved

BIOS Capital Management, LP first disclosed a stake in ACTU in Q4 2024 at 9,893,651 shares (US$78.8M). The position peaked in Q3 2026 at 10,049,996 shares, worth US$7.84B. Across 8 filings, BIOS Capital Management, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 10,049,996 shares valued at US$7.84B.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 9.89M $78.75M New
Q1 2025 9.89M $66.98M Hold
Q2 2025 9.97M $60.89M Add
Q3 2025 10.05M $67.23M Add
Q4 2025 10.05M $61.51M Hold
Q1 2026 10.05M $27.54M Hold
Q2 2026 10.05M $15.38M Hold
Q3 2026 10.05M $7.84B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACTU and 13F data

ACTU (ACTUATE THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in ACTU — the largest reported positions include Voss Capital, LP (US$2.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACTU

All ACTU fund holders →

FAQ

How long has BIOS Capital Management, LP held ACTU?

BIOS Capital Management, LP has disclosed ACTU holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is BIOS Capital Management, LP's current position in ACTU?

As of Q3 2026, BIOS Capital Management, LP holds 10.05M shares of ACTU (ACTUATE THERAPEUTICS INC), valued at $7.84B, representing 22.94% of its reported portfolio and ranking #2.

Has BIOS Capital Management, LP been buying or selling ACTU?

In the latest 13F filing (Q3 2026), BIOS Capital Management, LP held unchanged its position in ACTU. The position peaked in Q3 2026 at 10.05M shares.

Which other funds hold ACTU?

Other major institutional holders of ACTU include Voss Capital, LP, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.